In the absence of a fully matched donor, adult patients with Acute Leukemia (AML and ALL)
in CR are nowadays usually offered, as a first choice, an allogeneic transplant from an …

Background. Optimal post-remission strategy for patients with acute myeloid leukemia (AML)
is still matter of debate. Allogeneic Stem Cell Transplant (allo-HSCT) is the most effective …

This is a retrospective comparison of partially mismatched related donor transplantation
(PMRDT) and autotransplantation (ABMT) in advanced acute leukemia. Patients underwent …

Background. The best donor source for adult patients with acute leukemia lacking an HLA-
identical donor still remains to be established. The objective of this study was to compare the …

“Beijing group” has pioneered a different approach with T-cell replete HID, intensive
myeloablation, a combination of G-CSF-primed bone marrow plus peripheral blood as the …

Background Allogeneic hematopoietic cell transplantation (allo‐HCT) is the only cure for
acute myeloid leukemia (AML) in second complete remission (CR2). Patients lacking a …

Objectives: Allogeneic bone-marrow transplantation (BMT) is an established treatment for
many haematological malignancies. Unfortunately, most patients lack an HLA genotypically …

In the absence of HLA-matched related and unrelated donors, alternative donors must be
found for patients in need of allogeneic hematopoietic cell transplantation (HCT). There are …

Allogeneic hematopoietic stem cell transplantation is the optimal care for patients with high-
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …

Purpose Establishment of hematopoietic stem-cell (HSC) transplantation from mismatched
relatives is feasible for patients with acute leukemia. As our original method of graft …